Literature DB >> 6418013

Susceptibility of insect-borne, metacyclic forms of Trypanosoma cruzi to antibody-mediated mechanisms of destruction.

F Kierszenbaum, M F Lima.   

Abstract

The effect of passive antibody transfer against infection with vector-borne, metacylic forms of Trypanosoma cruzi, and possible mechanisms of immunologic lysis of these organisms, were examined in this work. Anti-T. cruzi antibodies from mice surviving an infection conferred marked protection against challenge with a lethal dose (2,000 organisms) of metacyclic flagellates isolated from the reduviid insect Rhodnius prolixus. In vitro lysis of these parasites by immune sera from mice or chronic chagasic patients was found to require complement (C) activity since the phenomenon was abrogated by heating the sera at 56 degrees C, adding the C inactivator cobra venom factor or in the absence of divalent cations. The lytic activity was provided via the alternative pathway of C activation since it was readily demonstrable in the absence of calcium ions. The metacyclic trypanosomes were also killed by human lymphocytes, neutrophils and eosinophils in the presence of anti-T. cruzi antibodies. Minimal or insignificant cytotoxicity was afforded by the cells or the antibodies when tested separately. These results emphasize the beneficial role of the humoral immune response in host defense against challenge with the form of T. cruzi responsible for natural infections.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6418013     DOI: 10.4269/ajtmh.1983.32.1236

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  6 in total

1.  Modulation of sensitivity of blood forms of Trypanosoma cruzi to antibody-mediated, complement-dependent lysis.

Authors:  F Kierszenbaum; M A Ramirez
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

2.  A partial cDNA clone of trypomastigote decay-accelerating factor (T-DAF), a developmentally regulated complement inhibitor of Trypanosoma cruzi, has genetic and functional similarities to the human complement inhibitor DAF.

Authors:  D V Tambourgi; T L Kipnis; W D da Silva; K A Joiner; A Sher; S Heath; B F Hall; G B Ogden
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

3.  Trypanosoma cruzi suppresses the expression of the p75 chain of interleukin-2 receptors on the surface of activated helper and cytotoxic human lymphocytes.

Authors:  F Kierszenbaum; M B Sztein
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

4.  A lytic monoclonal antibody to Trypanosoma cruzi bloodstream trypomastigotes which recognizes an epitope expressed in tissues affected in Chagas' disease.

Authors:  N W Zwirner; E L Malchiodi; M G Chiaramonte; C A Fossati
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

5.  Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B.

Authors:  K Joiner; A Sher; T Gaither; C Hammer
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

6.  Amastigotes of Trypanosoma cruzi escape destruction by the terminal complement components.

Authors:  K Iida; M B Whitlow; V Nussenzweig
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.